Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7686105rdf:typepubmed:Citationlld:pubmed
pubmed-article:7686105lifeskim:mentionsumls-concept:C1267092lld:lifeskim
pubmed-article:7686105lifeskim:mentionsumls-concept:C0458827lld:lifeskim
pubmed-article:7686105lifeskim:mentionsumls-concept:C0001644lld:lifeskim
pubmed-article:7686105lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:7686105lifeskim:mentionsumls-concept:C0035028lld:lifeskim
pubmed-article:7686105lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:7686105lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:7686105lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:7686105pubmed:issue1lld:pubmed
pubmed-article:7686105pubmed:dateCreated1993-7-29lld:pubmed
pubmed-article:7686105pubmed:abstractTextIn isolated guinea pig trachea contracted by 0.5 mM acetylcholine, the cumulative relaxant concentration-response curves to the beta 2-adrenoceptor agonist, salbutamol, were shifted to the right by depolarizing concentrations of KCl, as well as by charybdotoxin, iberiotoxin and tetraethylammonium ion, which are antagonists of the high-conductance Ca(2+)-activated K+ channel. The shifts produced by KCl (40 mM), charybdotoxin (100 nM), iberiotoxin (50 nM), and tetraethylammonium ion (2 mM) were approximately 230-fold, 10-fold, 78-fold, and 8-fold, respectively. The blockade of beta 2-adrenoceptor agonist-induced relaxation by these agents was totally reversed by 0.3 microM nifedipine. Similar reversal was obtained with either 100 microM CdCl2, or low Ca2+ (50 microM) Krebs medium. These data suggest that charybdotoxin, iberiotoxin and tetraethylammonium ion, like KCl, cause membrane depolarization which in turn activates voltage-dependent Ca2+ channels. The influx of Ca2+ via these channels provides an additional mode to that of release of intracellular Ca2+ evoked by acetylcholine for maintaining cell Ca2+ concentration at a high level. This is apparently sufficient to account functionally for the blockade of beta 2-adrenoceptor agonist-induced relaxation. In view of this interpretation regarding the action of Ca(2+)-activated K+ channel antagonists, earlier proposals ascribing the relaxant effect of beta 2-adrenoceptor agonists strictly to activation of these channels must be reevaluated.lld:pubmed
pubmed-article:7686105pubmed:languageenglld:pubmed
pubmed-article:7686105pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:citationSubsetIMlld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7686105pubmed:statusMEDLINElld:pubmed
pubmed-article:7686105pubmed:monthAprlld:pubmed
pubmed-article:7686105pubmed:issn0014-2999lld:pubmed
pubmed-article:7686105pubmed:authorpubmed-author:ReubenJ PJPlld:pubmed
pubmed-article:7686105pubmed:authorpubmed-author:GarciaM LMLlld:pubmed
pubmed-article:7686105pubmed:authorpubmed-author:HuangJ CJClld:pubmed
pubmed-article:7686105pubmed:authorpubmed-author:KacsorowskiG...lld:pubmed
pubmed-article:7686105pubmed:issnTypePrintlld:pubmed
pubmed-article:7686105pubmed:day22lld:pubmed
pubmed-article:7686105pubmed:volume235lld:pubmed
pubmed-article:7686105pubmed:ownerNLMlld:pubmed
pubmed-article:7686105pubmed:authorsCompleteYlld:pubmed
pubmed-article:7686105pubmed:pagination37-43lld:pubmed
pubmed-article:7686105pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:meshHeadingpubmed-meshheading:7686105-...lld:pubmed
pubmed-article:7686105pubmed:year1993lld:pubmed
pubmed-article:7686105pubmed:articleTitleInhibition of beta-adrenoceptor agonist relaxation of airway smooth muscle by Ca(2+)-activated K+ channel blockers.lld:pubmed
pubmed-article:7686105pubmed:affiliationDepartment of Membrane Biochemistry and Biophysics, Merck Research Laboratories, Rahway, NJ 07065.lld:pubmed
pubmed-article:7686105pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7686105pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7686105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7686105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7686105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7686105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7686105lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7686105lld:pubmed